Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma

Clinical trial NCT07388563 · SUSPENDED

Trial details

NCT number: NCT07388563
Sponsor: National Cancer Institute (NCI)
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, T Cell, Peripheral T-cell Lymphoma Angioimmunoblastic T-cell Lymphoma Anaplastic Large Cell Lymphoma Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Adult T-cell Leukemia/Lymphoma

Start date: 2026-03-26
Primary completion: 2027-03-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.